Eureka 02002L0098-20090807 Sign in

blood component release

as defined in Directive 2002/98/EC of the European Parliament and of the Council of 27…, Article 3, point (i) (Definitions)

(i) 

‘blood component release’ shall mean a process which enables a blood component to be released from a quarantine status by the use of systems and procedures to ensure that the finished product meets its release specification;

Open in the act with Eureka

Install the extension for EUR-Lex